3AI Holding and Seetha Mahalaxmi Healthcare India partner to jointly own and enhance multilingual genAI platform 'Hanooman'.
3AI Holding and Seetha Mahalaxmi Healthcare (SML) India have entered a strategic partnership to jointly own the multilingual genAI platform 'Hanooman'. SML introduced Hanooman in February, and 3AI Holding's homegrown proprietary patent pending Omega generative AI will make it more powerful. The platform aims to reach 200 million users across 22 Indian languages within its first year, launching on May 1, 2024.
April 04, 2024
6 Articles